170 related articles for article (PubMed ID: 22891645)
1. Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT).
Deng H; O'Keefe H; Davie CP; Lind KE; Acharya RA; Franklin GJ; Larkin J; Matico R; Neeb M; Thompson MM; Lohr T; Gross JW; Centrella PA; O'Donovan GK; Bedard KL; van Vloten K; Mataruse S; Skinner SR; Belyanskaya SL; Carpenter TY; Shearer TW; Clark MA; Cuozzo JW; Arico-Muendel CC; Morgan BA
J Med Chem; 2012 Aug; 55(16):7061-79. PubMed ID: 22891645
[TBL] [Abstract][Full Text] [Related]
2. The amelioration of cartilage degeneration by ADAMTS-5 inhibitor delivered in a hyaluronic acid hydrogel.
Chen P; Zhu S; Wang Y; Mu Q; Wu Y; Xia Q; Zhang X; Sun H; Tao J; Hu H; Lu P; Ouyang H
Biomaterials; 2014 Mar; 35(9):2827-36. PubMed ID: 24424207
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent and Selective Inhibitors for ADAMTS-4 through DNA-Encoded Library Technology (ELT).
Ding Y; O'Keefe H; DeLorey JL; Israel DI; Messer JA; Chiu CH; Skinner SR; Matico RE; Murray-Thompson MF; Li F; Clark MA; Cuozzo JW; Arico-Muendel C; Morgan BA
ACS Med Chem Lett; 2015 Aug; 6(8):888-93. PubMed ID: 26288689
[TBL] [Abstract][Full Text] [Related]
4. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.
Song RH; Tortorella MD; Malfait AM; Alston JT; Yang Z; Arner EC; Griggs DW
Arthritis Rheum; 2007 Feb; 56(2):575-85. PubMed ID: 17265492
[TBL] [Abstract][Full Text] [Related]
5. Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification.
Larkin J; Lohr TA; Elefante L; Shearin J; Matico R; Su JL; Xue Y; Liu F; Genell C; Miller RE; Tran PB; Malfait AM; Maier CC; Matheny CJ
Osteoarthritis Cartilage; 2015 Aug; 23(8):1254-66. PubMed ID: 25800415
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of lentivirus-mediated siRNA targeting ADAMTS-5 on cartilage degradation in a rat model of osteoarthritis.
Chu X; You H; Yuan X; Zhao W; Li W; Guo X
Int J Mol Med; 2013 May; 31(5):1222-8. PubMed ID: 23546441
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
Sawaji Y; Hynes J; Vincent T; Saklatvala J
Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
[TBL] [Abstract][Full Text] [Related]
8. 5-((1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5.
Gilbert AM; Bursavich MG; Lombardi S; Georgiadis KE; Reifenberg E; Flannery CR; Morris EA
Bioorg Med Chem Lett; 2007 Mar; 17(5):1189-92. PubMed ID: 17210252
[TBL] [Abstract][Full Text] [Related]
9. Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis.
Brebion F; Gosmini R; Deprez P; Varin M; Peixoto C; Alvey L; Jary H; Bienvenu N; Triballeau N; Blanque R; Cottereaux C; Christophe T; Vandervoort N; Mollat P; Touitou R; Leonard P; De Ceuninck F; Botez I; Monjardet A; van der Aar E; Amantini D
J Med Chem; 2021 Mar; 64(6):2937-2952. PubMed ID: 33719441
[TBL] [Abstract][Full Text] [Related]
10. The Anti-ADAMTS-5 Nanobody
Siebuhr AS; Werkmann D; Bay-Jensen AC; Thudium CS; Karsdal MA; Serruys B; Ladel C; Michaelis M; Lindemann S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825512
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis.
Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS
Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343
[TBL] [Abstract][Full Text] [Related]
12. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.
Verma P; Dalal K
J Cell Biochem; 2011 Dec; 112(12):3507-14. PubMed ID: 21815191
[TBL] [Abstract][Full Text] [Related]
13. Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.
Durham TB; Klimkowski VJ; Rito CJ; Marimuthu J; Toth JL; Liu C; Durbin JD; Stout SL; Adams L; Swearingen C; Lin C; Chambers MG; Thirunavukkarasu K; Wiley MR
J Med Chem; 2014 Dec; 57(24):10476-85. PubMed ID: 25415648
[TBL] [Abstract][Full Text] [Related]
14. The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities.
Moncada-Pazos A; Obaya AJ; Viloria CG; López-Otín C; Cal S
J Mol Med (Berl); 2011 Jun; 89(6):611-9. PubMed ID: 21365186
[TBL] [Abstract][Full Text] [Related]
15. VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts.
Pérez-García S; Carrión M; Gutiérrez-Cañas I; González-Álvaro I; Gomariz RP; Juarranz Y
J Cell Mol Med; 2016 Apr; 20(4):678-87. PubMed ID: 26818776
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 17 is necessary for cartilage aggrecan degradation in an inflammatory environment.
Clements KM; Flannelly JK; Tart J; Brockbank SM; Wardale J; Freeth J; Parker AE; Newham P
Ann Rheum Dis; 2011 Apr; 70(4):683-9. PubMed ID: 21216815
[TBL] [Abstract][Full Text] [Related]
17. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
[TBL] [Abstract][Full Text] [Related]
18. Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis.
Apte SS
Biochem J; 2016 Jan; 473(1):e1-4. PubMed ID: 26657033
[TBL] [Abstract][Full Text] [Related]
19. Evidence of a novel aggrecan-degrading activity in cartilage: Studies of mice deficient in both ADAMTS-4 and ADAMTS-5.
Rogerson FM; Stanton H; East CJ; Golub SB; Tutolo L; Farmer PJ; Fosang AJ
Arthritis Rheum; 2008 Jun; 58(6):1664-73. PubMed ID: 18512787
[TBL] [Abstract][Full Text] [Related]
20. Antibody-based exosite inhibitors of ADAMTS-5 (aggrecanase-2).
Santamaria S; Yamamoto K; Botkjaer K; Tape C; Dyson MR; McCafferty J; Murphy G; Nagase H
Biochem J; 2015 Nov; 471(3):391-401. PubMed ID: 26303525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
